Pub. Date : 2002 Oct
PMID : 12364422
4 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | Raloxifene administration in women treated with gonadotropin-releasing hormone agonist for uterine leiomyomas: effects on bone metabolism. | Raloxifene Hydrochloride | gonadotropin releasing hormone 1 | Homo sapiens |
2 | This prospective randomized, single-blind, placebo-controlled clinical trial was performed to evaluate the efficacy of raloxifene in preventing the bone loss associated with GnRH agonist (GnRH-a) administration. | Raloxifene Hydrochloride | gonadotropin releasing hormone 1 | Homo sapiens |
3 | This prospective randomized, single-blind, placebo-controlled clinical trial was performed to evaluate the efficacy of raloxifene in preventing the bone loss associated with GnRH agonist (GnRH-a) administration. | Raloxifene Hydrochloride | gonadotropin releasing hormone 1 | Homo sapiens |
4 | In conclusion, raloxifene prevents GnRH-a related bone loss in premenopausal women with uterine leiomyomas. | Raloxifene Hydrochloride | gonadotropin releasing hormone 1 | Homo sapiens |